Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2026-01-05 @ 7:57 AM
Study NCT ID:
NCT02648035
Status:
COMPLETED
Last Update Posted:
2019-03-25
First Post:
2016-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-22
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-20
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-05
First Submit QC Date:
None
Study First Post Date:
2016-01-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-22
Last Update Post Date:
2019-03-25
Last Update Post Date Type:
ACTUAL